[{"id":"9557a613-c303-410a-b30d-bcfd807825f2","acronym":"HERT-GBM","url":"https://clinicaltrials.gov/study/NCT01109095","created_at":"2021-01-18T04:23:31.492Z","updated_at":"2024-07-02T16:37:00.202Z","phase":"Phase 1","brief_title":"CMV-specific Cytotoxic T Lymphocytes Expressing CAR Targeting HER2 in Patients With GBM","source_id_and_acronym":"NCT01109095 - HERT-GBM","lead_sponsor":"Baylor College of Medicine","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 positive • HER-2 expression","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 positive • HER-2 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e AU-105"],"overall_status":"Completed","enrollment":" Enrollment 16","initiation":"Initiation: 10/01/2010","start_date":" 10/01/2010","primary_txt":" Primary completion: 06/01/2014","primary_completion_date":" 06/01/2014","study_txt":" Completion: 03/07/2018","study_completion_date":" 03/07/2018","last_update_posted":"2019-04-25"}]